Your browser doesn't support javascript.
loading
Elevated plasma galectin-3 levels and their correlation with disease activity in adult-onset Still's disease.
Chen, Po-Ku; Lan, Joung-Liang; Li, Ju-Pi; Chang, Ching-Kun; Chang, Shih-Hsin; Huang, Po-Hao; Yeo, Kai-Jieh; Chen, Der-Yuan.
Afiliação
  • Chen PK; Translational Medicine Laboratory, Rheumatic Diseases Research Center, China Medical University Hospital, Taichung, Taiwan.
  • Lan JL; College of Medicine, China Medical University, Taichung, Taiwan.
  • Li JP; College of Medicine, China Medical University, Taichung, Taiwan.
  • Chang CK; Rheumatic Diseases Research Center, China Medical University Hospital, Taichung, Taiwan.
  • Chang SH; Rheumatology and Immunology Center, China Medical University Hospital, No. 2, Yude Road, Taichung, 40447, Taiwan.
  • Huang PH; College of Medicine, China Medical University, Taichung, Taiwan.
  • Yeo KJ; Rheumatic Diseases Research Center, China Medical University Hospital, Taichung, Taiwan.
  • Chen DY; Translational Medicine Laboratory, Rheumatic Diseases Research Center, China Medical University Hospital, Taichung, Taiwan.
Clin Rheumatol ; 39(6): 1945-1952, 2020 Jun.
Article em En | MEDLINE | ID: mdl-31960208
ABSTRACT

OBJECTIVES:

With galectin-3 playing an important role in inflammatory responses, elevated galectin-3 levels have been shown in patients with autoimmune diseases. However, there are limited data regarding galectin-3 expression in patients with autoinflammatory diseases such as adult-onset Still's disease (AOSD). This study aimed to investigate the extracellular galectin-3 expression and examine its association with activity parameters and disease outcome in AOSD patients.

METHOD:

Plasma levels of galectin-3 and inflammasome downstream cytokines including interleukin (IL)-1ß and IL-18 were determined by ELISA in 42 active AOSD patients and 20 healthy controls (HC). The protein levels of galectin-3 and cytokines were determined using immunoblotting.

RESULTS:

Plasma levels of galectin-3 and inflammasome downstream cytokines including IL-1ß and IL-18 were significantly higher in AOSD patients (median 5.02 ng/ml, interquartile range [IQR] 3.12-7.88 ng/ml; 3.42 pg/ml, IQR 1.48-6.70 pg/ml; and 5758 pg/ml, IQR 859-11,895 pg/ml, respectively) compared with HC (1.86 ng/ml, IQR 1.09-2.89 ng/ml; 0.99 pg/ml, IQR 0.62-1.35 pg/ml; and 129 pg/ml, IQR 71-155 pg/ml, respectively, all p < 0.001). Plasma galectin-3 levels were positively correlated with clinical activity scores, inflammatory parameters values, and the levels of IL-1ß and IL-18 in AOSD patients. AOSD patients with systemic pattern had significantly higher galectin-3 levels (median 6.08 ng/ml, IQR 4.01-9.54 ng/ml) compared with those with chronic articular pattern (3.56 ng/ml, IQR 3.04-4.98 ng/ml, p < 0.05). After 6-month therapy, galectin-3 levels significantly declined, paralleling the decreases in clinical activity scores and plasma levels of IL-1ß and IL-18.

CONCLUSIONS:

Elevated galectin-3 levels and their positive correlation with disease activity scores, inflammatory parameter, and inflammasome downstream cytokines suggest the involvement of galectin-3 in AOSD pathogenesis.Key Points• We revealed for the first time the association of plasma galectin-3 levels with AOSD activity parameters.• We explored the link between galectin-3 levels and NLRP3-inflammasome downstream cytokines in AOSD disease.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Still de Início Tardio / Galectina 3 / Inflamassomos Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Still de Início Tardio / Galectina 3 / Inflamassomos Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article